Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.
Bécouarn Y, Ychou M, Ducreux M, Borel C, Bertheault-Cvitkovic F, Seitz JF, Nasca S, Nguyen TD, Paillot B, Raoul JL, Duffour J, Fandi A, Dupont-André G, Rougier P. Bécouarn Y, et al. Among authors: nasca s. J Clin Oncol. 1998 Aug;16(8):2739-44. doi: 10.1200/JCO.1998.16.8.2739. J Clin Oncol. 1998. PMID: 9704726 Clinical Trial.
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.
Seitz JF, Bennouna J, Paillot B, Gamelin E, François E, Conroy T, Raoul JL, Becouarn Y, Bertheault-Cvitkovic F, Ychou M, Nasca S, Fandi A, Barthelemy P, Douillard JY. Seitz JF, et al. Among authors: nasca s. Ann Oncol. 2002 Jul;13(7):1072-9. doi: 10.1093/annonc/mdf183. Ann Oncol. 2002. PMID: 12176786 Free article. Clinical Trial.
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.
Conroy T, Paillot B, François E, Bugat R, Jacob JH, Stein U, Nasca S, Metges JP, Rixe O, Michel P, Magherini E, Hua A, Deplanque G. Conroy T, et al. Among authors: nasca s. J Clin Oncol. 2005 Feb 20;23(6):1228-36. doi: 10.1200/JCO.2005.06.050. J Clin Oncol. 2005. PMID: 15718320 Clinical Trial.
Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial.
Borget I, Aupérin A, Pignon JP, Abbas M, Bouché O, Mousseau M, Raoul JL, Bedenne L, Cassan P, Clavero-Fabri MC, Stremsdoerfer N, Nasca S, Queuniet AM, Ducreux M; Fédération Francophone de Cancérologie Digestive. Borget I, et al. Among authors: nasca s. Oncology. 2006;71(1-2):40-8. doi: 10.1159/000100448. Epub 2007 Mar 5. Oncology. 2006. PMID: 17344670 Clinical Trial.
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study.
Peiffert D, Seitz JF, Rougier P, François E, Cvitkovic F, Mirabel X, Nasca S, Ducreux M, Hannoun-Levi JM, Lusinchi A, Debrigode E, Conroy T, Pignon JP, Gérard JP. Peiffert D, et al. Among authors: nasca s. Ann Oncol. 1997 Jun;8(6):575-81. doi: 10.1023/a:1008295119573. Ann Oncol. 1997. PMID: 9261527 Free article. Clinical Trial.
Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
Roussel A, Jacob JH, Haegele P, Jung GM, Paillot B, Heintz JP, Gignoux M, Nasca S, Namer A, Bleiberg H, et al. Roussel A, et al. Among authors: nasca s. Recent Results Cancer Res. 1988;110:21-9. doi: 10.1007/978-3-642-83293-2_3. Recent Results Cancer Res. 1988. PMID: 3043591 Clinical Trial. No abstract available.
42 results